O
ANAB icon

OppenheimerFunds’s AnaptysBio ANAB Stock Holding History

OppenheimerFunds’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$78.6M Buy
1,075,890
+3,671
+0.3% +$253K 0.1% 216
2018
Q4 		$68.4M Sell
1,072,219
-24,325
-2% -$1.81M 0.1% 208
2018
Q3 		$109M Sell
1,096,544
-5,343
-0.5% -$443K 0.13% 179
2018
Q2 		$78.3M Buy
1,101,887
+54,773
+5% +$4.59M 0.09% 238
2018
Q1 		$109M Sell
1,047,114
-12,267
-1% -$1.38M 0.14% 170
2017
Q4 		$107M Buy
+1,059,381
New +$78M 0.13% 179

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

OppenheimerFunds's ANAB Position: Q1 2019 in Review

OppenheimerFunds increased its AnaptysBio (ANAB) stake by 0.34% in Q1 2019, buying an estimated $253K and bringing the position to 1,075,890 shares worth $78.6M. The position accounts for 0.1% of the portfolio, ranked #216.

OppenheimerFunds first reported a position in ANAB in Q4 2017 and has held it in 6 quarters since. The position peaked at $109M in Q3 2018. 129 funds tracked by Wall St. Rank hold ANAB as of Q1 2019.

  • OppenheimerFunds held 1,075,890 shares of AnaptysBio worth $78.6M as of Q1 2019.
  • OppenheimerFunds bought 3,671 AnaptysBio shares in Q1 2019, an estimated $253K.
  • AnaptysBio made up 0.1% of OppenheimerFunds's portfolio in Q1 2019, its #216 holding.
  • OppenheimerFunds first reported a position in AnaptysBio in Q4 2017 and has held it in 6 quarters since.
  • OppenheimerFunds's AnaptysBio position peaked at $109M in Q3 2018.
  • 129 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.